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Herbal medicines are often combinations of botanical extracts that are assumed to have additive or
synergistic effects. The purpose of this investigation was to compare the effect of individual botanical
extracts with combinations of extracts on prostate cell viability. We then modeled the interactions
between botanical extracts in combination isobolographically. Scutellaria baicalensis, Rabdosia
rubescens, Panax-pseudo ginseng, Dendranthema morifolium, Glycyrrhiza uralensis and Serenoa
repens were collected, taxonomically identified and extracts prepared. Effects of the extracts on cell
viability were quantitated in prostate cell lines using a luminescent ATP cell viability assay. Combina-
tions of two botanical extracts of the four most active extracts were tested in the 22Rv1 cell line and their
interactions assessed using isobolographic analysis. Each extract significantly inhibited the proliferation
of prostate cell lines in a time- and dose-dependent manner except S. repens. The most active extracts,
S. baicalensis, D. morifolium, G. uralensis and R. rubescens were tested as two-extract combinations.
S. baicalensis and D. morifolium when combined were additive with a trend toward synergy, whereas
D. morifolium and R. rubescens together were additive. The remaining two-extract combinations
showed antagonism. The four extracts together were significantly more effective than the two-by-two
combinations and the individual extracts alone. Combining the four herbal extracts significantly
enhanced their activity in the cell lines tested compared with extracts alone. The less predictable
nature of the two-way combinations suggests a need for careful characterization of the effects of each
individual herb based on their intended use.
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Introduction
In Chinese medicine, formulas such as Huangquin-tang (1)
which contain combinations of natural ingredients are
prescribed for the treatment of prostate cancer. These
combinations are intended to attain increased potency due to
synergistic interactions between the individual components,
such that the combination is superior to individual herbal
treatment alone. Creating herbal mixtures as opposed to
utilizing a single, active herb can present the benefit of lower
doses of each individual herb, thus reducing the incidence
of dose-related side effects at the same bioeffective dose of a
single herb. This treatment philosophy is consistent with the
systemic theory of treating chronic diseases, which advocates
the inclusion of many active organic substances in formulas
to not only treat the disease but to create homeostasis within
the body (2).
Interactions between organic substances have been tested in
limited fashion in herbal combinations and have demonstrated
the possibility of antagonism as well as synergism. In a recent
report (3) of eight herbs from the PCSPES formula for prostate
cancer, the most cytotoxic herb (P. notoginseng) was varied
with respect to the rest of the mixture, and isobolographic ana-
lysis carried out on the resulting data. The analysis revealed
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herbs in the formula, even though the complete PCSPES
mixture had been shown to effectively inhibit cancer cell
viability in several prior studies (4,5). Therefore, the present
analysis was designed to further assess the actions and interac-
tions of plant extracts from the PCSPES formula (Scutellaria
baicalensis, Rabdosia rubescens, Panax-pseudo ginseng,
Dendranthema morifolium, Glycyrrhiza uralensis and
Serenoa repens) separately and in combination, in a prostate
cancer cell model.
The plants that were acquired were chosen due to either
their inclusion in traditional Chinese formulas for prostate
cancer or based on published reports of their effects in
prostate cancer cell lines and/or patients. Effects that have
been reported for these extracts include: the inhibition of pro-
liferation in prostate, oral, colon and breast cancer cells (6),
a decrease in PSA and androgen receptor expression in LNCaP
prostate cancer cells, induction of apoptosis via caspase-
3 activation (7) and immune stimulating properties (8). Other
observed effects show the induction of G1 and G2/M cell cycle
arrest in prostate cancer, leukemia and hepatic cancer cell
lines (9–12) and decreased COX-2 and Bcl2 expression in
prostate cancer cell lines (13). S. repens, in particular, is
widely known for its ability to alleviate frequency of urination
in men with benign prostatic hyperplasia (BPH) (14–16).
Studies have also shown that treatment with S. repens is
associated with prostatic epithelial contraction and decre-
ases in tissue dihydrotestosterone (DHT) levels in men with
BPH (17,18).
Three prostate cancer cell lines were studied including
an immortalized prostate epithelial cell line derived from a
histologically normal adult human prostate and two cell lines
of differing invasiveness to assess the effects of the botanicals
in a model of the multistep process of carcinogenesis. The
interactions among the four most potent extracts in the
22Rv1 prostate carcinoma cell line were then analyzed using
isobolographic analysis. This method was first introduced by
Loewe (19) in 1928 and has been widely utilized in interaction
studies of both drugs and herbs (3,20–22). In contrast to
traditional means of statistical analyzing dose-effect data
which merely shows an effect but does not distinguish between
additivity and synergy, isobolographic analysis depicts this
difference graphically thus allowing for a visual assessment
of the interaction. We then calculated a combination index
(CI) for the data, to mathematically compare the observed
response with the expected, calculated response. In addition
to the two-way combinations, a mixture of the four most potent
extracts was also tested in the viability assay and compared
with controls and the two-way mixtures.
Methods
Plant Materials and Extracts
Plant materials were collected, authenticated, extracted and
standardized as previously reported by our laboratory (23).
Briefly, the aerial parts of the Chinese herbs (S. baicalensis,
R. rubescens, P. ginseng, D. morifolium and G. uralensis)
were collected and authenticated in China by Phytomedical
Research, Inc. (Beijing, China), and extracted by Botanica
Biosciences (Ojai, CA, USA), in 70% ethanol : water.
Commercial standards of baicalin, baicalein, chlorogenic
acid and fatty acids were purchased from Sigma (St Louis,
MO, USA). Ginsenosides and wogonin were purchased from
Indofine (Hillsborough, NJ, USA). Commercial standard of
oridonin was purchased from Herbstandard, Inc. (Chesterfield,
MO, USA). Dried berries of Saw Palmetto (Florida, USA)
were extracted sequentially in cold hexane, acetone and then
ethanol at the Phytochemistry Laboratory of the Center for
Human Nutrition, UCLA,USA. Solvent was removed in vacuo
at low temperature to yield hexane, acetone and ethanol
extracts, respectively. The Saw Palmetto extract was analyzed
for fatty acid content by gas chromatography (GC). The
extracts ofthe Chinese herbs were analyzed for their respective
chemical marker compounds (referenced above) by high-
performance liquid chromatography as previously reported
(23). For cell culture assays, herb extracts were dissolved
in DMSO with the exception of G. uralensis, which was
dissolved in 70% ethanol, and sterile filtered with a 0.22 mm
Millex -GP filter unit (Millipore Corporation, Billerica,
MA, USA).
Cell Culture
All cell lines were acquired from American Type Culture
Collection (Rockville, MD, USA). 22Rv1 prostate cancer
cells were grown in RPMI 1640 containing 10% fetal bovine
serum (FBS) in the presence of 100 U ml
 1 of penicillin and
0.1 g l
 1 of streptomycin. RWPE-1 and RWPE-2 prostate cells
were grown in Defined Keratinocyte Serum Free Medium
(DKSFM) containing epidermal growth factor (EGF), insulin
and fibroblast growth factor (FGF). Cells were incubated
at 37 C with 95% air and 5% CO2. All cells were maintained
below passage 20 and used in experiments during the linear
phase of growth.
ATP Assay
Cells were plated in 96-well plates at a density of 5000 cells
per well for 22Rv1 cells and 10000 cells per well for
RWPE-1 and RWPE-2 cells and allowed to attach for 24 h.
Cells were then treated with either media, vehicle control
( 0.30% DMSO,  0.15% ethanol individually for individual
extract tests or in combination where extract mixtures were
used) or the appropriate treatments for 24, 48 and 72 h. Viab-
ility was measured utilizing the CellTiter-Glo  Luminescent
Cell Viability Assay (Promega, Madison, WI, USA). When
added to cells, the assay reagent produces luminescence in
the presence of ATP from viable cells. Results were read
on the Orion Microplate Luminometer (Bertholds Detection
Systems, Pforzheim, Germany). Values obtained were subtrac-
ted from blank wells containing media and vehicle (no cells)
to control for the effects of vehicles on the luminescence
118 Botanical interactions in prostate cancer cellsreagents. Treatment values were then divided by vehicle con-
trol values to obtain percent change from control. Due to the
large number of data collected from six extracts and three
cell lines, only the concentration curve from the 48 h time
point is shown.
Analysis of Antiproliferative Effect and Synergism
EC50 values for each herbal extract were determined through
linear regression with the GraphPad Prism 4 software program
(GraphPad Software, Inc., San Diego, CA, USA). In combina-
tion experiments, extracts were added at equipotent quantities
and at
1⁄2 and
1⁄4 fractions of their IC50 value. To assess synergy
and antagonism, experimentally derived date was plotted on an
isobologram and a CI was determined according to the method
of Mertens–Talcott (18).
Statistical Analysis
Results are presented as mean values ± SE. Data were ana-
lyzed by either one-way ANOVA followed by Dunnet’s test
(a ¼ 0.05) to compare experimental means with controls
using GraphPad Prism 4 software. To compare statistical dif-
ferences between theoretical and experimental means in the
Figure 1. Herbal extracts inhibit proliferation in prostate cell lines. I. S. baicalensis II. G. uralensis III. D. morifolium IV. R. rubescens V. P. ginseng VI. S.
repens. Cells were exposed to increasing concentrations of herbal extracts for 48 hours. Cell proliferation was determined via the CellTiter-Glo  Luminescent
Cell Viability Assay. Data are expressed as a percentage of vehicle treated controls, mean ± SE (n ¼ 3).
*P < 0.01 compared to vehicle controls.
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was accepted.
Results
Inhibition of Viability with Individual Extracts
Each of the individual extracts significantly inhibited viability
of the three prostate cell lines tested in a dose-dependent man-
ner, with the exception of S. repens in the 22Rv1 cell line
(P   0.001) (Fig. 1, I–VI). There was no significant difference
between media and vehicle-treated controls as confirmed by
two-tailed Student’s t-test (ethanol: RWPE-1 P   0.2008,
RWPE-2 P   0.848, 22Rv1 P   0.6098; DMSO: RWPE-1
P   0.787, RWPE-2 P   0.766, 22Rv1 P   0.6098). The
EC50 values obtained for each extract treatment are shown in
Table 1. The four extracts that are most effective in inhibiting
cell viability in these three cell lines include S. baicalensis,
G. uralensis, D. morifolium and R. rubescens. Therefore, these
extracts were chosen for further analysis as combinations of
two herbs and all four together.
Two-way and Four-way Combination Treatments
Two-way combination studies of the four herbs exhibited
varying inhibitory activities in the 22Rv1 cell line (Fig. 2).
Inhibition of viability >50% of controls was taken to be
indicative of additive or enhanced inhibition of growth since
all botanical extracts were added at the concentration known
to result in 50% inhibition when tested individually. No signi-
ficant difference between media and vehicle-treated controls
was observed as confirmed by two-tailed Student’s t-test
(P ¼ 0.530). The mixture of D. morifolium and S. baicalensis
was the most effective combination treatment, resulting in
72% inhibition of cell viability compared with vehicle control
(P   0.001). Similarly, the combination of D. morifolium and
R. rubescens inhibited cell viability 57% compared with vehi-
cle controls (P   0.001). All other two-extract combinations
resulted in <50% inhibition of cell viability. Nonetheless,
all but one of the combinations tested resulted in significant
inhibition of cell viability compared with controls. However,
when the four herbs were combined into a single treatment
(Quad), the result was an 88% inhibition of viability
(P   0.001) compared with vehicle controls (Fig. 2).
Isobolographic Analysis
Isobolographic analysis was performed utilizing the EC50 val-
ues of each botanical extract at a 1 : 1 ratio and at appropriate
dilutions of this dose ratio. The dose-effect data and statistics
for the isobolograms are shown in Table 2. Plotting the EC50
value of one herb of a combination on the x-axis and the other
on the y-axis yielded the isobolograms shown in Fig. 3. The
line connecting the two points on the graph demonstrates all
combinations that would theoretically result in additivity.
The combination of D. morifolium and R. rubescens falls on
the line of additivity, which indicates an additive reaction
with this combination. The S. baicalensis and D. morifolium
combination fell below the line of additivity; however, the dis-
tance was not significant. The other four combinations all fell
above the line of additivity; however, only one was not signi-
ficant (S. baicalensis and G. uralensis). The remaining three
combinations (R. rubescens and G. uralensis, S. baicalensis
and R. rubescens) were significantly different from the line
of additivity (P < 0.05) indicating antagonistic interactions.
Combination Index
Utilizing the EC50 values of each individual herb and the
EC50 value of the combinations, the CI was derived to evaluate
the level of interaction between the two herbs (18). Consistent
with the results of the isobologram, the combination of
S. baicalensis and D. morifolium was somewhat <1 (0.968),
thecombinationofD.morifoliumandR.rubescenswasslightly
>1 (1.299) and the CI for the S. baicalensis and G. uralensis
combination was 2.034. These are the three combinations
that were not significantly different from the theoretical
additive dose. Alternatively, S. baicalensis and R. rubescens
had a CI of 3.984, G. uralensis and R. rubescens was 7.98,
Figure 2. Herbal combinations inhibit proliferation in 22Rv1 prostate cancer
cell line. Cells were exposed to two by two and a four way mixture (Quad) of
the four herbs tested at EC50 levels for the 22Rv1 cell line for 48 hours. Data
are expressed as a percentage of vehicle treated controls, mean ± SE (n   3).
Asterisks indicate significance from vehicle controls (single asterisk: P  
0.001, double asterisk: P   0.05).
Table 1. EC50 values of individual herbal extracts in prostate cell lines
Extract EC50 value (mgm l
 1)
22Rv1 RWPE-1 RWPE-2
S. baicalensis 61.55 59.00 53.00
G. uralensis 94.64 9.00 11.00
D. morifolium 130.96 181.00 139.00
R. rubescens 45.00 12.50 11.00
P. ginseng >200 >200 >200
S. repens >200 121.00 134.00
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S. baicalensis D. morifolium S. baicalensis G. uralensis
Dose Effect Dose Effect Dose Effect Dose Effect
(mgm l
 1) (% inhibition) (mgm l
 1) (% inhibition) (mgm l
 1) (% inhibition) (mgm l
 1) (% inhibition)
25 0.1724 25 0.1262 25 0.1724 25 0.1585
50 0.3086 50 0.2116 50 0.3086 50 0.3098
100 0.7521 100 0.3800 100 0.7521 100 0.5133
200 0.9947 200 0.6826 200 0.9947 200 0.7051
Combination Combination
Dose Effect Dose Effect
(mgm l
 1) (% inhibition) (mgm l
 1) (% inhibition)
46.55 0.2619 39.02 0.2700
69.83 0.3081 58.53 0.3100
93.10 0.7206 78.04 0.4300
Additive parameters Experimental parameters Additive parameters Experimental parameters
f ¼ 0.5 p(sc) ¼ 0.3197 Y ¼  2.198 þ 1.428 log(x) f ¼ 0.5 p(sc) ¼ 0.3951 Y ¼  0.6436 þ 0.557 log(x)
p(den) ¼ 0.6803 p(gly) ¼ 0.6049
log (mix) ¼ 1.8890 log (mix) ¼ 2.0530
Add ¼ 96.22 mix ¼ 77.4462 Add ¼ 77.86 mix ¼ 112.9796
S. baicalensis R. rubescens G. uralensis D. morifolium
Dose Effect Dose Effect Dose Effect Dose Effect
(mgm l
 1) (% inhibition) (mgm l
 1) (% inhibition) (mgm l
 1) (% inhibition) (mgm l
 1) (% inhibition)
25 0.1724 25 0.3199 25 0.1585 25 0.1262
50 0.3086 50 0.3600 50 0.3098 50 0.2116
100 0.7521 100 0.7687 100 0.5133 100 0.3800
200 0.9947 200 0.9250 200 0.7051 200 0.6826
Combination Combination
Dose Effect Dose Effect
(mgm l
 1) (% inhibition) (mgm l
 1) (% inhibition)
27.84 0.1200 54.70 0.1200
41.75 0.2000 82.05 0.2100
55.67 0.2900 109.40 0.2200
Additive parameters Experimental parameters Additive parameters Experimental parameters
f ¼ 0.5 p(sc) ¼ 0.5777 Y ¼  0.7362 þ 0.5933 log(x) f ¼ 0.5 p(gly) ¼ 0.4184 Y ¼  0.4188 þ 0.3126 log(x)
p(rap) ¼ 0.4223 p(den) ¼ 0.5816
log (mix) ¼ 2.0840 log (mix) ¼ 2.9390
Add ¼ 53.25 mix ¼ 121.3389 Add ¼ 112.58 mix ¼ 868.9604
D. morifolium R. rubescens G. uralensis R. rubescens
Dose Effect Dose Effect Dose Effect Dose Effect
(mgm l
 1) (% inhibition) (mgm l
 1) (% inhibition) (mgm l
 1) (% inhibition) (mgm l
 1) (% inhibition)
25 0.1262 25 0.3199 25 0.1585 25 0.3199
50 0.2116 50 0.3600 50 0.3098 50 0.3600
100 0.3800 100 0.7687 100 0.5133 100 0.7687
200 0.6826 200 0.9250 200 0.7051 200 0.9250
Combination Combination
Dose Effect Dose Effect
(mgm l
 1) (% inhibition) (mgm l
 1) (% inhibition)
43.52 0.0340 35.99 0.1200
65.27 0.1100 53.98 0.1800
87.03 0.5700 71.97 0.2500
Additive parameters Experimental parameters Additive parameters Experimental parameters
f ¼ 0.5 p(den) ¼ 0.7443 Y ¼  2.777 þ 1.674 log(x) f ¼ 0.5 p(gly) ¼ 0.6767 Y ¼  0.5187 þ 0.4075 log(x)
p(rab) ¼ 0.2557 p(rab) ¼ 0.3232
log (mix) ¼ 1.9580 log (mix) ¼ 2.4990
Add ¼ 87.95 mix ¼ 90.7821 Add ¼ 69.59 mix ¼ 315.5005
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of 15.026 (Table 3). These values reflect the isobologram
showing that these combinations were significantly greater
than the theoretical additive dose, indicating antagonism.
Discussion
The purpose of this investigation was 2-fold. First, we deter-
mined the activity of six widely used natural extracts from a
well-known Chinese medicine combination (PCSPES) in
different prostate cancer cell lines representing stages in the
multistage process of prostate carcinogenesis. Second, we
analyzed the interactions between the different herbs in
combination, in a selected humanprostate epithelial carcinoma
cell line (22Rv1). These studies demonstrated varying effects
of the four individual herbs on prostate cancer cells in vitro.
S. baicalensis, R. rubescens, G. uralensis and D. morifolium
have been shown to inhibit viability in LNCaP prostate
cancer cells in vitro. In this same report, S. baicalensis and
Figure 3. Isobologram demonstrating the interaction of two-by-two herbal combinations. The solid line represents the line of additivity (dose: mg/mL); the broken
line represents proportions of the mixtures. Point A represents the calculated additive response where point B indicates the response achieved by testing.
Table 3. Interaction indices for herbal combinations
Combination Combination index P-value
S. baicalensis and D. morifolium 0.968 0.571
D. morifolium and R. rubescens 1.299 0.318
S. baicalensis and G. uralensis 2.034 0.242
S. baicalensis and R. rubescens 3.984 0.015
G. uralensis and R. rubescens 7.980 0.031
G. uralensis and D. morifolium 15.026 0.058
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expression (24). Both a flavonoid in S. baicalensis, baicalin,
and its aglycone form, baicalein, inhibited viability in
DU145, LNCaP and PC-3 prostate cancer cell lines and
induced apoptosis via caspase-3 activation (7), and induced
G1 and G2/M cell cycle arrest in prostate cancer, leukemia
and hepatic cancer cell lines (9–12). Oridonin, an extract
of R. rubescens, decreased bcl2 and increased bax
expression in SPCA-1 lung cancer cells (25) and showed anti-
angiogenic properties in an endothelial cell-based assay for
angiogenesis (26).
The results of our initial viability studies confirm the effects
observed with these same botanical extracts in previous studies
of various prostate cancer cell lines (4,5). We found that botan-
ical extracts from S. baicalensis, G. uralensis, D. morifolium
and R. rubescens among the six that were tested showed sub-
stantial activity in these cell lines. S. repens and P. ginseng
have been reported to reduce proliferation in LNCaP prostate
cancer cells (13,27). These extracts were the least effective
in RWPE-1, RWPE-2 and 22RV1 cells; therefore, the com-
bination studies did not include these extracts. However, cell
line specific effects are known to occur and natural compounds
may act in either direct or indirect fashion. Indirect action of a
compound may affect tissues or compounds outside of the cell
and therefore not exhibit detectable activity in a cell culture
model. An example of this would be the decrease of tissue
DHT levels in vivo after treatment with S. repens (17,18).
Isobolographic analysis of the four most potent botanical
extracts was studied in the 22Rv1 cell line which is the most
aggressive prostate cancer cell line of the three tested. Our
results indicate that some of the two-by-two combinations
displayed additive effects suggesting that similar molecular
targets or metabolic pathways are involved in their action.
The combination of S. baicalensis and D. morifolium fell
below the line of additivity indicating a trend toward synergy;
however, this was not statistically significant.
Four of the combinations displayed clear antagonism. Of
the four antagonistic combinations, three contain G. uralensis
and two contain S. baicalensis. S. baicalensis and G. uralensis
together inhibit each other to the point of rendering their action
insignificant. It is unlikely that one extract would have an
action in the cell that directly opposes inhibition of viability
by another extract, as all of them individually result in the
inhibition of cell viability. This observation affords us with
opportunity for future studies into the mechanisms of these
extracts.
More importantly, despite the interactions of the extracts in
two-by-two combinations, the overall effect of the absolute
mixture was to inhibit cell viability to 88%. This observation is
consistent with the idea that combinations of botanical extracts
are more effective than isolated components in the mixture.
These interactions may depend upon the complimentary nature
of different families of compounds in each of the extracts. This
principle was demonstrated for food phytochemical extracts in
a recent report which demonstrated that tomato powder con-
taining lycopene, phytoene, phytofluene in a complex mixture
but not purified lycopene was able to inhibit prostate carcino-
genesis in the NMU-testosterone mouse model (28).
The limitations in this work are related to the in vitro method
used to evaluate cell viability, which may not reflect the
conditions in vivo following absorption and metabolism of
the extracts. As previously stated, while direct action may be
observed in a cell culture model, indirect actions would
unlikely be observed. Nonetheless, these findings provide
valuable insight into the effect of the individual botanical
extracts on prostate cancer cell viability and encourage invest-
igation into the inhibitory targets and metabolic pathways
affected by the botanical materials tested. The results of the
isobologram suggest that unknown factors influencing the
action of the extracts make their interactions unpredictable.
The ratio of one extract to another, the mode of action and
the necessity of common cellular resources are only some
examples of variables that may determine the efficacy of a
mixture. Therefore, comprehension of the activity of each
extract when alone and in combination is essential to designing
effective mixtures.
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